|
Titel: Intana Announces Agreement with Johnson&Johnson to Provide Proprietary Spectroscopy Technology |
|
|
|
Quelle: |
Intana Bioscience GmbH |
|
|
|
|
|
Text:
|
Martinsried, Germany, July 7th, 2010. Intana Bioscience GmbH announced today that it has
entered an agreement with Johnson & Johnson Pharmaceutical Research & Development, a
division of Janssen Pharmaceutica N.V., Beerse, Belgium. Under the agreement, Intana will
provide its proprietary Fluorescent Cross Correlation Spectroscopy (FCCS) technology
platform to screen for small molecule inhibitors of a set of target proteins.
FCCS is a spectroscopic method to measure the interactions of molecules in solution, based
on the sensitive detection of single molecules. The proprietary technology of Intana
Bioscience allows FCCS to be performed in cellular lysates, thereby characterizing the
interactions between small molecules and their target proteins in approximately
physiological conditions.
In the course of this collaboration, Intana will develop assays and establish a medium to high
throughput screening platform for drug discovery projects at Janssen Pharmaceutica N.V.
Additionally the technology will provide access to the binding kinetics of identified inhibitors,
in support of lead optimization.
About Intana
Intana Bioscience is a privately©\held biotechnology company based in Munich/Martinsried,
Germany. As service provider Intana supports pharmaceutical and biotechnology companies
in their drug discovery efforts using Fluorescence Cross Correlation Spectroscopy ©\ FCCS. The
technology can be used to characterize drug target interactions with respect to affinity and
kinetic parameters. Measurements can be carried out in cellular lysates, thereby
circumventing tedious protein purification and providing physiological conditions for
measurements. Customers benefit from short assay development times and precise affinity
determination in a physiological environment. Intana receives seed financing by European
investors BioM, High©\Tech Gr¨¹nderfonds and Bayern Kapital.
For further inquiries, please contact:
Dr. Frank Becker
Intana Bioscience GmbH
Lochhamer Str. 29a
82152 Planegg
Germany
Phone: +49©\(0)89©\895572©\80
Fax: +49©\(0)89©\895572©\81
info@intana.de
www.intana.de |
|
Datei: |
|
|
|
|
Online:
07.07.2010 |
|